Results

Total Results: over 10,000 records

Showing results for "applicable".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-final-app-c.xlsx
    January 01, 2025 - Overall accuracy of cancer signal of origin: 83%; By cancer: liver (90%); lung (64%); pancreas (not applicable … Nanomaterial-Assisted LDI for Cancer Identification N number NGS next generation sequencing NA not applicable
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-future_research.pdf
    March 01, 2012 - inhibitors and ARBs have similar rates of treatment adherence based on pill counts; this result may not be applicable
  3. hcup-us.ahrq.gov/db/nation/nass/NASSIntroduction2021.pdf
    April 01, 2024 - Introduction To The HCUP Nationwide Ambulatory Surgery Sample HEALTHCARE COST AND UTILIZATION PROJECT — HCUP A FEDERAL-STATE-INDUSTRY PARTNERSHIP IN HEALTH DATA Sponsored by the Agency for Healthcare Research and Quality INTRODUCTION TO THE HCUP NATIONWIDE AMBULATORY SURGERY SAMPLE (NASS) 2021 …
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/sleep-apnea-diagnosis-future_research.pdf
    February 01, 2012 - Future Research Needs for Diagnosis of Obstructive Sleep Apnea Future Research Needs Paper Number 11 Future Research Needs for Diagnosis of Obstructive Sleep Apnea Future Research Needs Paper Number 11 Future Research Needs for Diagnosis of Obstructive Sleep Apnea Identification of Future Research …
  5. hcup-us.ahrq.gov/db/nation/nass/NASSIntroduction2022.pdf
    December 01, 2024 - Introduction to the NASS, 2022 HEALTHCARE COST AND UTILIZATION PROJECT — HCUP A FEDERAL-STATE-INDUSTRY PARTNERSHIP IN HEALTH DATA Sponsored by the Agency for Healthcare Research and Quality INTRODUCTION TO THE HCUP NATIONWIDE AMBULATORY SURGERY SAMPLE (NASS) 2022 These pages pr…
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/vaccine-safety_disposition-comments.pdf
    January 01, 2020 - We have added further information regarding why evidence is considered “insufficient” where applicable … Not all decision-makers are equally versed in applicable areas of epidemiology and clinical medicine
  7. www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patientsafetyculture/hospital/2016/2016_hospitalsops_report_pt1.pdf
    January 01, 2016 - 140 250 140/250= 56% Composite Score % Positive = (46% + 52% + 46% + 56%) / 4 = 50% * NA = Not applicable … NA* 106 240 106/240=44% * NA = Not applicable.
  8. www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2021qdr-datasources.pdf
    December 31, 2021 - Risk-adjusted rates for all applicable QIs are provided. … factor of 0.980 to the Outpatient Prospective Payment System (OPPS) payments and copayments for all applicable
  9. hcup-us.ahrq.gov/reports/methods/2005_02.pdf
    January 01, 2005 - medical record coders assign the ICD-9-CM diagnosis codes for ED visits and ICD-9-CM procedure codes if applicable … Beyond this, some specific challenges to collecting additional data that is applicable to ED settings
  10. www.uspreventiveservicestaskforce.org/home/getfilebytoken/3qpQqeeozW8nV3a4_BWntp
    June 20, 2019 - None Not applicable No controlled studies or observational studies link screening directly to health … None Not applicable No evidence. 7a 1.
  11. www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/mui/mui-screening-toolkit.pdf
    April 01, 2025 - EHR to alert providers within a pa- tient’s medical chart if they screened positively for UI, and if applicable … your practice should be mindful of how UI screening aligns with incentives in your practice and, if applicable
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/lysosomal-storage-diseases-therapies_disposition-comments.pdf
    January 01, 2014 - Disposition of Comments Report for Enzyme-Replacement Therapies for Lysosomal Storage Disease Source: http://effectivehealthcare.ahrq.gov/search-for-guides-reviews-and- reports/?pageaction=displayproduct&productID=1368 Published Online: January 2, 2013 Technical Brief Disposition of Comments Report Resear…
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-infection-prevention-mdro-rapid-research.pdf
    April 01, 2024 - Making Healthcare Safer IV Rapid Review: Prevention in Adults of Infection With Transmission of Multidrug-Resistant Organisms Making Healthcare Safer IV Prevention in Adults of Transmission of Infection With Multidrug-Resistant Organisms Rapid Review Structured Abstract Objectives. This rapid review …
  14. www.uspreventiveservicestaskforce.org/home/getfilebytoken/9Ks34K-BnsDSBK4MYDATYS
    August 09, 2016 - Studies conducted in very high Human Development Index coun- tries are more likely to be applicable to
  15. www.uspreventiveservicestaskforce.org/home/getfilebytoken/cJSpoZqW2M7czx_-GeTdtE
    May 01, 2004 - NA, not applicable. AHRQ Pub. No. 04-0540-B May 200429
  16. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-2007_executive.pdf
    January 01, 2007 - Effectiveness studies that would be most applicable to the broad population of depressed patients are
  17. digital.ahrq.gov/sites/default/files/docs/publication/r18hs018646-gance-cleveland-final-report-2014.pdf
    January 01, 2014 - were rated on a 4-point Likert-type scale from strongly disagree (1) to strongly agree (4) or not applicable
  18. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_executive.pdf
    October 01, 2010 - The following information was obtained from each trial, if applicable: author identification; year of
  19. www.ahrq.gov/sites/default/files/wysiwyg/sops/surveys/medical-office/2020_MOSOPS_Part_I-rev0921.pdf
    January 01, 2020 - 125 260 125/260= 48% Composite Measures % Positive Score = (46% + 56% + 48%) / 3 = 50% *NA = Not applicable
  20. www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/failure-to-rescue-1.pdf
    March 01, 2020 - This section reviews applicable studies in more depth, organized by measure type (process and outcome